Board meetings are a recurring event and they inform stakeholders of the likely event and happening at the firm. In fact they are a mandatory event that are to be stipulated to be held. So, apart from the regular earnings here are 3 board meetings lined up for Buyback, Amalgamation and Bonus
The pharma company Zydus Lifesciences is slated to be meet on May 20, 2022 to discuss on quarterly earnings, dividend and share buyback. On the buyback front, the company's filing mentioned that the company has now informed BSE that the Board of Directors of the Company, at its aforesaid meeting, will also consider a proposal for buyback of fully paid-up equity shares of the Company and the matters necessary and incidental thereto, in accordance with the applicable provisions under the Companies Act, 2013 (including the rules and regulations framed thereunder), the Securities and Exchange Board of India (Buy-back of Securities) Regulations, 2018, as amended, and other applicable laws.
Also, at the same time the company shall announce final dividend for the Fy22. The company's shares last quoted at Rs. 352.75 per share
Shree Renuka Sugars
The company's board will meet on May 24 to discuss audited result and amalgamation. As per the filing the company shall meet up for the following
To consider and approve Standalone & Consolidated Audited Financial Results of the Company for the year ended 315 March 2022
To consider merger of Monica Trading Private Limited, Shree Renuka Agri Ventures Limited & Shree Renuka Tunaport Private Limited, wholly owned subsidiaries of the Company, with the Company, subject to necessary approvals.
This mid-cap auto components and equipment firm has announced of its board meet on May 24. The company then will
consider and approve the following matters:
Audited Standalone and Consolidated Financial Results of the Company for the Quarter and Year ended on March 31, 2022.
Audited Standalone and Consolidated Financial Statements of the Company for the Year ended on March 31, 2022.
To consider and recommend final dividend on equity and preference shares, if any, for the Financial Year 2021-22.
To consider and recommend issue of Bonus Shares, subject to shareholders and other requisite approvals.
Raising of funds through issue of debt securities upto Rs. 1000 Crores in one or more tranches, subject to shareholders and other requisite approvals.
The ''Trading Window'' for dealing in the Securities of the Company shall remain closed for all Directors/ Officers/ designated persons of the Company till 48 hours after the results are made public on May 24, 2022.
The above board meetings are mentioned for their likely agendas and is not an advice for investment in them.